Sutro Biopharma (STRO) EBITDA Margin (QoQ) (2017 - 2025)
Powered by 
Analysis
Sutro Biopharma (STRO) EBITDA Margin (QoQ) (2017 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Sutro Biopharma | 334.33 Mn | 169.99 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -7,656.00 |
| Sep 30, 2025 | -49,469.00 |
| Jun 30, 2025 | 38,853.00 |
| Mar 31, 2025 | 4,688.00 |
| Dec 31, 2024 | 35,651.00 |
| Sep 30, 2024 | -60,778.00 |
| Jun 30, 2024 | 24,566.00 |
| Mar 31, 2024 | -47,299.00 |
| Dec 31, 2023 | 29,801.00 |
| Sep 30, 2023 | 18,345.00 |
| Jun 30, 2023 | -11,026.00 |
| Mar 31, 2023 | 23,697.00 |
| Dec 31, 2022 | -48,588.00 |
| Sep 30, 2022 | -1,537.00 |
| Jun 30, 2022 | 59,462.00 |
| Mar 31, 2022 | -33,474.00 |
| Dec 31, 2021 | 7,826.00 |
| Sep 30, 2021 | -37,216.00 |
| Jun 30, 2021 | 9,471.00 |
| Mar 31, 2021 | 17,044.00 |